29 funding - 6,546,527€

data available since 2018
filter_list

2025

  1. RECURRENT AND REFRACTORY HIGH GRADE BRAIN TUMORS

  2. Enhancing CAR-T therapy through immunomodulation of the tumor microenvironment by blocking TIM-3: A dual approach for anti-tumor activity and preservation of cognitive function

    euro 279,146.00

2024

  1. FOXO as a central axis in DMG response to therapy.

    euro 61,020.00

  2. Sinergia entre el adenovirus oncolítico Delta-24-RGD con una nueva plataforma de virus adenoasociado, AAV, para el tratamiento del osteosarcoma pediátrico

    euro 75,000.00

  3. Immunomodulation of the tumor microenvironment in DIPG by oncolytic virotherapy.

    euro 126,000.00

  4. Overcoming resistance to oncolytic viruses for the treatment of Pediatric Diffuse Midline Gliomas

    euro 300,000.00

  5. Oncolytic viruses for pediatric brain tumors

    euro 118,441.00

  6. Combination Delta-24-RG & Paxalisib (treatment brain tumors

2023

  1. Overcoming resintance to virotherapy for pediatric brain tumors. PANDA

    euro 50,000.00

2022

  1. Phase 1 study of DNX-2401 for recurrent malignant brain tumo

  2. SEHOP-PENCIL study- Personalised Medicine for Cancer in Children in Spain Estrategia nacional para la implementación de la medicina personalizada en niños y adolescentes con cáncer A Spanish nation-wide strategy to implement personalised medicine in child

    euro 200,420.00

  3. Antibodies in mouse models of pediatric solid tumors

    euro 230,521.00

  4. Desarrollo y evaluación de virus oncolíticos portadores de n

  5. GRANATE - GRUPO DE RADIOTERAPIA AVANZADA DE NAVARRA ¿ TERAPIA Y EFICACIA

    euro 536,739.00

2021

  1. Terapias avanzadas para tumores sólidos pediátricos

    euro 360,000.00

  2. Combinatorial biotherapies for the treatment of pediatric diffuse midline glioma

    euro 300,000.00

  3. Remodeling the tumor microenvironment with biological therapies as treatment for Diffuse Intrinsic Pontine Gliomas

    euro 589,305.00

  4. Plasma extracellular vesicles (EVs): the key for precision medicine in Glioblastoma

    euro 38,720.00

  5. Estudio de los mecanismos implicados en el déficit neurocognitivo en supervivientes de un tumor cerebral infantil y desarrollo de estrategias terapéuticas que minimicen las secuelas neurológicas a largo plazo.

    euro 45,000.00

  6. CONVENIO DE COLABORACIÓN ENTRE FUNDACIÓN ADEY Y EL PROGRAMA

    euro 60,000.00